Ignite Creation Date:
2024-05-06 @ 1:52 AM
Last Modification Date:
2024-10-26 @ 11:11 AM
Study NCT ID:
NCT01925573
Status:
TERMINATED
Last Update Posted:
2022-02-03
First Post:
2013-08-13
Brief Title:
OptuneNOVOTTF-100A Bevacizumab Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma GCC 1344
Sponsor:
Organization:
University of Maryland Baltimore